Skip to Content

FDA Sends Letters to Companies for Misbranding and Marketing Unapproved Drugs

ROCKVILLE, Md., June 17, 2010--The FDA has posted on its website letters sent to companies for either misbranding or misleading consumers about their drugs or for marketing new and unapproved drugs.

Posted: June 2010

Recommended for you

View comments